Cipla has ended at Rs 309, up Rs 4.5 or 1.4%, on the BSE.
_____________________________________________
(Updated at 1105 am)
Cipla is quoting at Rs 312, higher by Rs 7 or 2.4%, on the BSE.
The stock opened at Rs 306 and has touched a high of Rs 313 and a low of Rs 305 thus far.
Cipla has recently launched generic versions of anti-flu drugs oseltamivir and zanamivir in the local market to treat the H1N1 influenza, which is spreading across the globe and in India. Cipla will brand oseltamivir as Antiflu and zanamivir as Virenza.
